FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4491211000001102: Anzemet 50mg tablets (Amdipharm) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18211901000001111 Anzemet 50mg tablets (Amdipharm) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54109101000001118 Anzemet 50mg tablets (Amdipharm Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Anzemet 50mg tablets (Amdipharm) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Is a Product containing precisely dolasetron mesilate 50 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has excipient Beeswax false Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has active ingredient Dolasetron mesilate false Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has active ingredient Dolasetron false Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has excipient Lactose false Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Is a Anzemet true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has specific active ingredient Dolasetron mesilate true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Anzemet 50mg tablets (Amdipharm) 3 tablet Is pack of False Anzemet 50mg tablets (Amdipharm) Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) 3 tablet Has AMP True Anzemet 50mg tablets (Amdipharm) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start